Cargando…

The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization

INTRODUCTION: We evaluated incidence, prevalence, costs, and healthcare utilization associated with systemic lupus erythematosus (SLE) in patients in Germany. METHODS: Adult patients with SLE were identified from the German Betriebskrankenkassen (BKK) health insurance fund database between 2009 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarting, Andreas, Friedel, Heiko, Garal-Pantaler, Elena, Pignot, Marc, Wang, Xia, Nab, Henk, Desta, Barnabas, Hammond, Edward R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991067/ https://www.ncbi.nlm.nih.gov/pubmed/33544369 http://dx.doi.org/10.1007/s40744-021-00277-0

Ejemplares similares

Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data
por: Clouth, Johannes, et al.
Publicado: (2018)

Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature
por: Hammond, Edward R, et al.
Publicado: (2020)

Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis
por: Murimi-Worstell, Irene B, et al.
Publicado: (2020)

Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015
por: Jiang, Miao, et al.
Publicado: (2021)

Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis
por: Samnaliev, Mihail, et al.
Publicado: (2021)

Epigenetic Aspects of Systemic Lupus Erythematosus
por: Relle, Manfred, et al.
Publicado: (2015)

Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis
por: Yazdany, Jinoos, et al.
Publicado: (2020)

Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015
por: Hammond, Edward R, et al.
Publicado: (2021)

Disease severity, flares and treatment patterns in adults with systemic lupus erythematosus in the UK: a real-world observational retrospective cohort analysis
por: Langham, Julia, et al.
Publicado: (2021)

The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis
por: Pego-Reigosa, José María, et al.
Publicado: (2020)

Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis
por: Bell, Christopher F, et al.
Publicado: (2023)

First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study
por: Schwarting, Andreas, et al.
Publicado: (2016)

The Burden of Living With Cutaneous Lupus Erythematosus
por: Drenkard, Cristina, et al.
Publicado: (2022)

Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus
por: Bruce, Ian N, et al.
Publicado: (2022)

Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study
por: Nyman, Elisabeth, et al.
Publicado: (2020)

Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus
por: Schwarting, A, et al.
Publicado: (2016)

Healthcare Utilization and Costs of Systemic Lupus Erythematosus in Medicaid
por: Kan, Hong J., et al.
Publicado: (2013)

Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort
por: Nikolopoulos, D, et al.
Publicado: (2020)

Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus
por: Wiseman, Stewart J., et al.
Publicado: (2016)

Administrative prevalence and incidence, characteristics and prescription patterns of patients with migraine in Germany: a retrospective claims data analysis
por: Roessler, Tatjana, et al.
Publicado: (2020)

Changes in referral, treatment and outcomes in patients with systemic lupus erythematosus in Germany in the 1990s and the 2000s
por: Albrecht, Katinka, et al.
Publicado: (2014)

Incidence and Risk of Infection in Egyptian Patients with Systemic Lupus Erythematosus
por: Mohamed, Dalia F, et al.
Publicado: (2014)

The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012
por: Rees, Frances, et al.
Publicado: (2016)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)

Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review
por: Oglesby, A., et al.
Publicado: (2013)

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2023)

Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
por: Meyer, Aurore, et al.
Publicado: (2020)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

Comparative Assessment of Different Health Utility Measures in Systemic Lupus Erythematosus
por: Wang, Su-li, et al.
Publicado: (2015)

Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation
por: Hassanalilou, Tohid, et al.
Publicado: (2017)

Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada
por: Fatoye, Francis, et al.
Publicado: (2018)

Myocardial Infarction in Systemic Lupus Erythematosus: Incidence and Coronary Angiography Findings
por: Tornvall, Per, et al.
Publicado: (2021)

Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
por: Hajji, Meriam, et al.
Publicado: (2023)

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project
por: Dall'Era, Maria C, et al.
Publicado: (2014)

Systemic lupus erythematosus.
por: Richardson, J.
Publicado: (1969)

Systemic Lupus Erythematosus
por: Peng, Stanford
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_svaertkn3e2aj1ltgpa2k3bvf8